XI'AN, China, Nov. 13, 2025 /PRNewswire/ -- Guangzhou Focus Biotechnology Co., Ltd., a subsidiary of KHB Group and an innovator in…
GUIYANG, China, Nov. 11, 2025 /PRNewswire/ -- The International Conference of Mountain Tourism and Outdoor Sports 2025 was inaugurated on…
Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in ACLF disease modelsSafety data from Phase 1 on…
November 08, 2025 17:13 ET | Source: Intellia Therapeutics, Inc. Deep, stable and durable reductions in kallikrein observed Among 32 patients…
GUIYANG, China, Nov. 7, 2025 /PRNewswire/ -- The International Conference of Mountain Tourism and Outdoor Sports (MTOS) 2025 is scheduled…
Julien's Auctions Presents Legendary Couture and Celebrity Fashion Featuring Cher, Tina Turner, Whitney Houston, Princess Diana, Beyoncé, Madonna, and More Live…
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…
Basel, October 19, 2025 – Novartis today presents new Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan) data from the Phase III PSMAddition…
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers and remains an aggressive disease with median survival…
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment…